Astrelis
Dialysis facility · Houston, TX

ELIK DIALYSIS HOME THERAPY

CCN 672626Latest FY 2025
Cost-report basis
HCRIS · as filed
Not audited by Astrelis

Operating margin: -533.4% in FY2025, the 0th percentile of 7,109 dialysis facilities in the FY2025 pool. Days cash on hand: 27 days in FY2025, the 54th percentile of 1,453 dialysis facilities in the FY2025 pool. Total operating revenue: $0.8M in FY2025, the 2nd percentile of 7,110 dialysis facilities in the FY2025 pool. Total margin (including nonoperating): +4.3% in FY2025, the 24th percentile of 7,110 dialysis facilities in the FY2025 pool. Figures as filed; not audited by Astrelis.

The read

A dialysis facility in Houston, TX. It ran an operating loss of 533.4% in FY25 on $0.8M of operating revenue. It held 27 days of cash on hand (54th percentile of 1,453 dialysis facilities on liquidity, FY25 pool). 6 reporting years are on file, but revenue scale shifts too much between them for a comparable trend, so trend context is limited. Including nonoperating items, the all-in result was positive at 4.3%.

Operating margin · FY25
-533.4%
Astrelis calculation · as-filed inputs
vs dialysis facilities0th pctl of 7,109 (FY25 pool)
pool: this metric's own fiscal year · excludes historical, non-panel, and out-of-range values
Days cash on hand · FY25
27d
all sources
Astrelis calculation · as-filed inputs
vs dialysis facilities54th pctl of 1,453 (FY25 pool)
pool: this metric's own fiscal year · excludes historical, non-panel, and out-of-range values
Total operating revenue · FY25
$0.8M
Astrelis calculation · as-filed inputs
vs dialysis facilities2nd pctl of 7,110 (FY25 pool)
pool: this metric's own fiscal year · excludes historical, non-panel, and out-of-range values
Total margin · incl. nonoperating · FY25
+4.3%
Astrelis calculation · as-filed inputs
vs dialysis facilities24th pctl of 7,110 (FY25 pool)
pool: this metric's own fiscal year · excludes historical, non-panel, and out-of-range values

Where ELIK DIALYSIS HOME sits among dialysis facilities

Operating margin · FY25 pool · n = 7,109 of 7,234 filed

Each point is one dialysis facility in the national FY25 distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market; that is the matched-peer comparison in the paid benchmark. The dialysis facility FY25 median is +16.8%. Descriptive context only, not a ranking.

-20%-10%0%+10%+20%dialysis facility median +16.8%ELIK DIALYSIS -533.4%
One dialysis facilityELIK DIALYSISdialysis facility median

The money

$ thousands · HCRIS cost-report basis · as filed, QA-gated

Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio computes only when every input is reported in the filing (otherwise its cell states which input is Not reported in source); a year whose balance sheet does not reconcile is labeled, and its derived ratios read Astrelis calculation unavailable. Not audited by Astrelis.

Operating margin
-533.4% (FY25)
Operating income ÷ total operating revenue
Astrelis calculation · HCRIS WS G-3
Total margin
+4.3% (FY25)
Net income ÷ total revenue incl. nonoperating
Astrelis calculation · HCRIS WS G-3
Days cash on hand
27d (FY25)
Cash & investments ÷ daily operating expense
Astrelis calculation · HCRIS WS G / G-3
Current ratio
8.23× (FY25)
Total current assets ÷ current liabilities
Astrelis calculation · HCRIS WS G
Equity financing ratio
51% (FY25)
Total net assets ÷ total assets
Astrelis calculation · HCRIS WS G
Days in net patient A/R
Not reported in source
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
Astrelis calculation · HCRIS WS G / G-3
$ in thousands
Line itemFY23FY24FY25
Patient revenue7,3095,535816
Total operating revenue7,3095,535816
Total operating expenses5,5115,5855,167
Operating income1,797(50)(4,351)
Operating margin %+24.6%-0.9%-533.4%
Other non-operating, net09344,585
Net income1,797884234
Net income %+24.6%+13.7%+4.3%
— = Not reported in source for that year.
HCRIS CMS-265 cost report · $ thousands · FY20–FY25 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
Display states. FY25 · Operating margin: -533.4% — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (beyond ±100%)

How it operates

quality & operational context · CMS public reporting

The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by provenance class and public source; descriptive context only, never a ranking or adequacy claim. Provenance labels: Reported value is copied from the named public source; Astrelis calculation is a formula applied to unchanged reported inputs, with the formula shown; Illustrative estimate is a benchmark gap, multiplier, or scenario — never a measurement.

Total treatments
1,881
Reported value2025
HCRIS CMS-265
Cost per treatment ($)
2,747
Astrelis calculation2025
HCRIS CMS-265
Net revenue per treatment ($)
433.67
Astrelis calculation2025
HCRIS CMS-265
Dialysis stations
1
Reported value2026
CMS Dialysis Facility Compare
Modalities offered
Peritoneal dialysis, Home hemodialysis training
Reported value2026
CMS Dialysis Facility Compare

Trajectory

Cost-report basis · 6 reporting years
Operating margin
+13.1%+5.5%-4.3%+24.6%-0.9%-533.4%FY20FY21FY22FY23FY24FY25
Days cash on hand
96 days37 days22 days57 days54 days27 daysFY20FY21FY22FY23FY24FY25

State context

Houston, TX
Located in Houston, TX. County-level statistics: linkage not established — this record's county mapping is not verified in the resolved spine, and we never place a facility in a county by guesswork. State-level context appears here once a state aggregate layer lands.
Operating margin vs its peer poolFY25Astrelis calculation

-533.4% operating margin — 0th percentile of 7,109 peers (FY25 pool).

The Board Briefing

What changed, what matters, and what your board should ask — every figure sourced to the public record.

Reserve The Board Briefing →
Performance Benchmark Report

($434 revenue vs $2,747 cost per treatment) = $2,313 per treatment below cost × 1,881 treatments ≈ $4.4M net spread at current volume · method
Reserve Performance Benchmark Report →
How we calculated this

Operating margin vs its peer pool: FY25 pool · n = 7,109.

Performance Benchmark Report: FY25 peer pool · n = 7,109 · conservative low band; acuity limits stated in the report.

Report coverage: Limited Facility Benchmark. 9 of 10 facility measures available from public sources. The report covers the available measures against their peer benchmarks; measures the public record does not carry become findings. Coverage is disclosed here before you reserve, and thin data is never a decline reason. The refund guarantee stands: if we cannot deliver the published scope, you pay nothing.

Portfolio Performance Review

A roster-priced triage of the per-facility benchmarks: every facility on your roster, benchmarked and sorted. Requires only a CCN roster.

From $7,500Founding Edition · built to order, first edition · priced by roster size · invoice after coverage confirmation · within 30 days
Request: scoped and quoted before any invoice. No payment is collected on this site.

Cite this page

release 2321a4fc37a7 · 2026-10-22

Astrelis Atlas, "Elik Dialysis Home Therapy", https://astrelis.co/providers/dialysis/672626, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Machine-readable twin of this page: astrelis.co/providers/dialysis/672626.md (Markdown, the same figures with their fiscal years, pools and definitions). Last modified: release 2321a4fc37a7, 2026-10-22. Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.

build 2321a4fc37a7 · 2026-10-22 · dev